Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression.
British journal of cancer 2013 Dec 109 (12): 3105-15.
Tan X, Wang Y, Han Y, Chang W, Su T, Hou J, Xu D, Yu Y, Ma W, Thompson T C, Cao
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 15, 2019
- Content source: